Condition: Rheumatoid Arthritis · Sponsor: University of Guadalajara
The objective of this clinical trial is to determine whether α-tocopherol (vitamin E) supplementation decreases inflammation and clinical activity in patients with rheumatoid arthritis (RA).The main questions to be answered are: * Is supplementation with vitamin E (α-tocopherol) for one month associated with decreased clinical activity and inflammation in patients with RA? Researchers will compare α-tocopherol with a placebo (a look-alike substance containing no active ingredient) to see if α-tocopherol effectively reduces inflammation and clinical activity in patients with rheumatoid arthritis. Participants will: * Take two capsules (one in the morning and one in the afternoon) of either α-tocopherol or placebo every day for a month. * Attend clinic visits at the start of the intervention (baseline) and at the end of the month for final check-ups and tests. * Keep a diary to record your symptoms and how often you take α-tocopherol or placebo.
This description comes directly from the study's public registry record.
Christian Johana J Baños Hernández, D.Sc. · +54 10585200 ó 7471493487 · johana.banos@academicos.udg.mx
Martin De Leon Cid, B.Nutr. · +54 4931817830 · martin.deleon9901@alumnos.udg.mx
Always discuss trial participation with your own doctor first.
| Civil Hospital of Guadalajara | Guadalajara, Jalisco, Mexico | Recruiting |
| Universidad de Guadalajara | Guadalajara, Jalisco, Mexico | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06915701